Nicotinamide + pyridoxine
Nicotinamide + pyridoxine has been studied in 4 papers since 2024: 1 trial in people, 1 in animals, 1 review; 1 in the past year. The newest paper, Mar 24, 2026: “Nicotinamide and Pyridoxine Supplementation Enhances Muscle Stem Cell Activity and Muscle Regeneration in Humans: A Randomized Placebo-Controlled Clinical Trial of High Force Eccentric Contraction Recovery in Healthy Young Men”.
4 papers study it11 findingsUpdated
See all 4 papers on nicotinamide + pyridoxine
At a glance
The findings reach people, from one lab or study. 3 independent labs in 3 countries.
“the number of Pax7, MyoD, and myogenin positive cells per damaged fiber was significantly higher in NAM/PN vs placebo groups (+29%-67%).”
None of its findings points the other way.
- 3 independent labs in 3 countries
- Funders: Nestle Health Science and others
- 8 of 10 findings with company ties
- Human trial1
- Animals1
Studies in people
1 study gave nicotinamide + pyridoxine to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Increases MuSC activity+29% up: Increases MyoD+ cells+67% up: Increases myogenin+ cells34% | Randomized trial9 days | 43 peoplemalesmean age of 26.7 yearsHealthy males aged 18 to 49 years | Advanced science (Weinheim, Baden-Wurttemberg, Germany), Mar 24, 2026 |
What did studies of nicotinamide + pyridoxine find?
10Studies of nicotinamide + pyridoxine measured 10 outcomes, among them muscle regeneration, muscle regeneration and Myogenin+ cells.
Muscle regeneration
upin humans1upin M. organisms1+37%
2 studies
Muscle regeneration
upin humans1upin M. organisms1+37%
Nicotinamide + pyridoxine increases muscle regeneration in humans following damaging unilateral eccentric muscle contractions (+37%).
“NAM/PN also increased the proportion of regenerating fibers (+37%).”
Human trialfollowing damaging unilateral eccentric muscle contractionsvastus lateralis muscle714 mg NAM and 19 mg PN daily9 daysmalesn = 39
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Nicotinamide + pyridoxine increases muscle regeneration in M. organisms.
“Oral treatment with a combination of NAM and PN accelerated muscle regeneration in vivo by stimulating MuSCs”
Animalsskeletal muscle
The Journal of clinical investigation
muscle regeneration
upin humans1+37%
1 study
muscle regeneration
upin humans1+37%
Nicotinamide + pyridoxine increases muscle regeneration in humans (+37%).
“Importantly, the percentage of damaged fibers expressing eMyHC+ at Day 8 was significantly higher in the NAM/PN group compared to placebo (Figure; +37%; p = 0.04), indicating that NAM/PN supplementation accelerates the differentiation of MuSCs into eMyHC+ regenerating fibers.”
Human trial9 daysn = 39
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Myogenin+ cells
upin humans1+34%
1 study
Myogenin+ cells
upin humans1+34%
Nicotinamide + pyridoxine increases myogenin+ cells in humans (34%).
“The supplementation of NAM/PN also significantly enhanced more terminal markers of myogenic differentiation as the number of myogenin+ cells was also significantly elevated in NAM/PN vs placebo compared to the placebo group (Figure; 34%; p = 0.029).”
Human trial9 daysn = 39
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
MyoD+ cells
upin humans1+67%
1 study
MyoD+ cells
upin humans1+67%
Nicotinamide + pyridoxine increases MyoD+ cells in humans (+67%).
“Consistently, the number of MyoD+ cells representing differentiating MuSCs was very robustly increased following NAM/PN vs placebo supplementation (Figure; +67%; p = 0.0002).”
Human trial9 daysn = 39
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
MuSC activity
upin humans1+29%
1 study
MuSC activity
upin humans1+29%
Nicotinamide + pyridoxine increases MuSC activity in humans (+29%).
“The supplementation of NAM/PN significantly increased the number of activated Pax7+ cells (Figure; +29%; p = 0.03 vs placebo), while the number of quiescent Pax7+ cells was not affected by the treatment.”
Human trial9 daysn = 39
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
MuSC activity
upin humans1
1 study
MuSC activity
upin humans1
Nicotinamide + pyridoxine increases muSC activity in humans following damaging unilateral eccentric muscle contractions (+29%-67%).
“the number of Pax7, MyoD, and myogenin positive cells per damaged fiber was significantly higher in NAM/PN vs placebo groups (+29%-67%).”
Human trialfollowing damaging unilateral eccentric muscle contractionsvastus lateralis muscle714 mg NAM and 19 mg PN daily9 daysmalesn = 39
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Short-term adverse effects
no changein humans1
1 study
Short-term adverse effects
no changein humans1
Nicotinamide + pyridoxine was not clearly linked with short-term adverse effects in humans (KYNU deficiency, treated from young age).
“which improved biochemistry without evident short-term adverse effects”
HumansKYNU deficiency, treated from young agen = 2
Molecular genetics and metabolism
Biochemistry
upin humans1
1 study
Biochemistry
upin humans1
Nicotinamide + pyridoxine is linked with better biochemistry in humans (KYNU deficiency, treated from young age).
“which improved biochemistry without evident short-term adverse effects”
HumansKYNU deficiency, treated from young agen = 2
Molecular genetics and metabolism
Muscle stem cell function
upin mice1
1 study
Muscle stem cell function
upin mice1
Nicotinamide + pyridoxine improves muscle stem cell function in mice.
“The combination of the two compounds promoted MuSC function in vivo in aged mice”
Reviewskeletal muscle
The Journal of clinical investigation
Muscle strength
upin M. organisms1
1 study
Muscle strength
upin M. organisms1
Nicotinamide + pyridoxine increases muscle strength in M. organisms during recovery.
“increased muscle strength during recovery”
Animalsduring recovery
The Journal of clinical investigation